the Clinical Effect of Nd: YAG Laser Assisted Periodontal Initial Therapy in Patients With Moderate to Severe Periodontitis
1 other identifier
interventional
22
1 country
1
Brief Summary
The goal of this clinical trial is to learn if Neodymium-Doped Yttrium Aluminum Garnet(Nd: YAG) Laser-assisted non-surgical periodontal treatment is effective in treating stage II/III periodontitis. It will also evaluate the safety and impact of the laser treatment. The main questions it aims to answer are:
- 1.Does Nd: YAG Laser treatment reduce probing depth, gingival inflammation, and clinical attachment loss more effectively than standard Scaling and root planing(SRP) therapy alone?
- 2.What changes in inflammatory markers and oxidative stress levels occur when patients receive laser-assisted therapy? Researchers will compare Nd: YAG Laser treatment to standard periodontal therapy alone to determine the effectiveness of the laser treatment.
- 3.Receive Nd: YAG Laser assisted therapy on one side of their mouth and standard therapy on the other side.
- 4.Visit the clinic at baseline, 6 weeks, and 3 months for follow-up assessments and tests.
- 5.Provide samples and have measurements taken of periodontal health and biomarkers of inflammation and oxidative stress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2024
CompletedStudy Start
First participant enrolled
September 4, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedSeptember 20, 2024
May 1, 2024
4 months
September 4, 2024
September 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Probing depth,PD
Probing depth refers to the distance from the gingival margin to the base of the periodontal pocket. It is measured using a periodontal probe at multiple sites around each tooth. A reduction in probing depth is indicative of periodontal health improvement following treatment.
Baseline,6 weeks,3months
Secondary Outcomes (5)
Gingival index,GI
Baseline,6 weeks,3months
Clinical attachment loss,CAL
Baseline,6 weeks,3months
Concentration of interleukin-6(IL-6)
Baseline,6 weeks,3months
Concentration of tumor necrosis factor-alpha(TNF-α)
Baseline,6 weeks,3months
Concentration of malondialdehyde(MDA)
Baseline,6 weeks,3months
Study Arms (2)
Control Group
ACTIVE COMPARATORThe control group will receive SRP alone
Laser Group
EXPERIMENTALThe laser group will receive SRP combined with Nd laser-assisted therapy
Interventions
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years, with no gender restrictions.
- Diagnosed with stage II or III periodontitis according to the 2018 Classification of Periodontal and Peri-Implant Diseases and Conditions.
- In each of the four quadrants of the oral cavity, at least one tooth must have at least one site with a probing depth ≥5 mm, clinical attachment loss ≥2 mm, and bleeding on probing.
- Participants must provide informed consent and sign the informed consent form.
You may not qualify if:
- Fewer than 20 remaining teeth (10 pairs of opposing teeth) or a significant discrepancy in the number of remaining teeth between the left and right sides of the mouth.
- Patients who have undergone periodontal treatment within the past six months or are currently undergoing orthodontic treatment, which may affect periodontal health.
- Patients with systemic diseases that could influence the outcomes of periodontal treatment.
- Patients with severe infections, malignancies, or other major diseases affecting overall health.
- Pregnant or breastfeeding women.
- Individuals with a history of smoking.
- Patients who are unable to comply with or complete periodontal treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
Related Publications (1)
Bian Z, Zhang H, Chen Y, Yang Y, Lin Q, Chen X, Chen L, Sun W, Tan J. Clinical effect of Nd:YAG laser-assisted non-surgical periodontal treatment on stage II/III periodontitis. J Dent. 2025 Nov;162:106056. doi: 10.1016/j.jdent.2025.106056. Epub 2025 Aug 26.
PMID: 40876623DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jingyi Tan, Doctor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2024
First Posted
September 19, 2024
Study Start
September 4, 2024
Primary Completion
December 20, 2024
Study Completion
December 30, 2024
Last Updated
September 20, 2024
Record last verified: 2024-05